PICO Portalanswers from OpenAlex & ORCID
H. Guo
ResearcherPublications, citations & collaboration network
H. Guo is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does H. Guo have?
PICO Portalindexed works
H. Guo has 6 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does H. Guo have?
PICO Portalcitation count
H. Guo has 0 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of H. Guo?
PICO Portalh-index
H. Guo has an h-index of 0 in OpenAlex.
What is the i10-index of H. Guo?
PICO Portali10-index
H. Guo has an i10-index of 0 in OpenAlex.
What is the OpenAlex record for H. Guo?
PICO Portalopenalex
The OpenAlex for H. Guo is on the source record.
What are the most-cited papers on H. Guo?
PICO Portalmost cited works
490MO Niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) in Chinese patients with breast cancer susceptibility gene (BRCA) altered metastatic castration-sensitive prostate cancer (mCSPC): Subgroup analysis of the phase III AMPLITUDE trial
B. Wang, D. Ye, H. Guo, L. Li, Suneel Mundle, F. Shen, Anildeep Singh, Y. Liu, Xiaoyu Jia, L. Han, N. Chen, H. Luo
573P Anatomical adaptability guides approach selection in robotic partial nephrectomy: Equivalent trifecta outcomes with route-specific predictive models
X. Zhen, L. Dai, Q. Ma, W. Yang, H. Guo, C. Ji
574P SHOX2-Mediated lymphatic metastasis in pT1 non-clear cell renal carcinoma: Biomarker-driven risk stratification and combined-modality management
Lina Dai, X. Zhen, Qian Ma, W. Yang, H. Guo, C. Ji
498P Efficacy and safety of triptorelin pamoate 22.5 mg 6-month formulation in Chinese patients with locally advanced or metastatic prostate cancer: A multicentre, single-arm phase IIIb study
S. Jiang, H. Su, H. Guo, M. Liu, Y. Li, G. Shi, J. Bi, Z. Chen, M. Chen, W. He, Z. Yan, J. Zhang, B. Xue, J-Y Zou, X. Shi, D. Ye
489MO A multicenter, single-arm, phase II trial of androgen deprivation therapy in combination with apalutamide in patients with high risk of recurrence after radical prostatectomy (ARES study)
Q. Zhang, L. Xu, X. Qiu, J. Zhuang, S. Zhang, C. Zhou, L. Xu, Haibo Xu, X. Wang, W. Liu, Xiaoyu Jia, H. Guo